Global Atenolol Tablets Market Size, Share and Trends Analysis Report, By Type (25mg, 50mg, and 100mg), and By Application (Hypertension, Angina, and Arrhythmias) Forecast (2022-2028)

The global atenolol tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atenolol is a beta-blocker drug used to treat excessive blood pressure and chest discomfort caused by the heart. However, atenolol does not appear to reduce mortality in people with high blood pressure. Other applications include migraine prophylaxis and the therapy of certain irregular heartbeats. The major factor driving the demand for atenolol tablets is the new product and treatment launch in atenolol tablets to control high blood pressure, chest pain, irregular heartbeat, among others across the globe.

 

For instance, in November 2020, Unichem Laboratories announced that the United States Food and Drug Administration (USFDA) has given its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg ANDA approval to market a common version of Alvogen Malta Operations’ TENORETIC (atenolol and chlorthalidone) Tablets. Tablets containing atenolol and chlorthalidone are used to treat hypertension and lower blood pressure. Unichem’s Ghaziabad factory will commercialize the product.

 

Some major players in the market include AstraZeneca plc, Aceto Co., Aurobindo Pharma Ltd., Sandoz International GmbH, Mylan N.V., among others. The market players are serving significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, in order to stay competitive in the market. For instance, in July 2019, Rising Pharmaceuticals, ACETO Corp.’s final dosage form generics subsidiary  launched Atenolol Tablets 25mg, 50mg, and 100mg, an FDA-approved generic version of Alvogen Malta Operations Ltd.’s reference listed medication, TENORMIN, which is intended for hypertension.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

·Competitive Landscape– AstraZeneca plc, Aceto Co., Aurobindo Pharma Ltd., Sandoz International GmbH, Mylan N.V., among others.

 

Key questions addressed by the report

 

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Atenolol Tablets Market Report by Segment

 

By Type

• 25mg
• 50mg
• 100mg

By Application

• Hypertension
• Angina
• Arrhythmias

 

Global Atenolol Tablets Market Report by Region

 

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa